Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 7, 2007Journal of Gastroenterology and HepatologyOpen Access

Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

XWXiong‐Zhi WuTianjin Nankai HospitalGXGuang Ru XieTianjin Medical University Cancer Institute and HospitalDCDan ChenZhengzhou Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2007) studied this question.

synapsesocial.com/papers/6a751df2e2936089dd033487https://doi.org/10.1111/j.1440-1746.2007.04997.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liver enriched transcription factors and differentiation of hepatocellular carcinoma.1999 · 95 citations
  2. 2Vitexin, an HIF-1α Inhibitor, Has Anti-metastatic Potential in PC12 Cells2006 · 71 citations
  3. 3Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth1997 · 1,091 citations
  4. 4Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines2004 · 72 citations